Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.
refid# ndry56B6LnrkdamqodER7Ezm9 pages
CIA POSITION STATEMENT: OCTOBER 2021 WWW.CIA.ORG.UK @SEE_CHEM_BUS RESPONSIBLE CARE ESSENTIAL USES CONCEPT - Is this viable for wider chemicals legislation?
refid# JNKdGkow7r21xwLreBYkBMbgv2 pages
SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products SUBSTANCES: per- and polyfluoroalkyl substances (PFAS) used for medicinal products FROM: European Federation of Pharmaceutical Industries and Associations (EFPIA) USE: For Human Medicinal Products DATE: 17 August 2023 PREPARED BY: EPPA SA/NV Place du Luxembourg 2 1050 Brussels, Belgium EU Transparency Register: 31367501249-92 SOCIO-ECONOMIC ANALYSIS | PFAS | EU REACH SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products PROJECT TITLE: Socio-economic analysis of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products VERSION: 17 August 2023 PREPARED FOR: European Federation of Pharmaceutical Industries and Associations (EFPIA) PERFORMED BY: EPPA (www.eppa.com) CITATION: EPPA, `Socio-economic analysis of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products', Report for EFPIA, July 2023 DISCLAIMER: The views expressed in this report are, unless otherwise stated, those of the authors and do not necessarily represent any official view of EFPIA and/or any other organization mentioned in this report. 2 CONTENTS SOCIO-ECONOMIC ANALYSIS | PFAS | EU REACH CONTENTS......................................................................................................................... 3 ABBREVIATIONS ................................................................................................................ 5 DEFINITIONS ..................................................................................................................... 7 1.
refid# MobGV8B18GX1ozRvz96NMYVj784 pages
TOXICOLOGICAL AND ECOTOXICOLOGICAL INFORMATION OF PFAS AND FLUOROPOLYMERS - RESPONSE TO DOSSIER CLAIMS BY CHEMOURS APM Introduction After thoroughly and carefully reviewing the PFAS Restriction Dossier and its Annexes, in this chapter we would like to take the opportunity of this consultation to respond to and correct certain misleading information/data regarding the toxicological and ecotoxicological information of PFAS, (particularly on fluoropolymers), which are currently presented in the Dossier/Annexes.
refid# 50JvaqJpj6rmpwjGdX62y375510 pages
2967858 it National Institute for Public Health $44 and the Environment Ministryof Health, Welfare and port J = U d. ndesanstalt fiir Arbeitsschutz wi Arbeitsmedizir K| Mi Swedish Chemicals Agency MNORWEGIAN IEERNTHINYIEY AGENCY 7 w= Ministry of Environment and Food of Denmark Environmental Protection Agency Summary page: 2nd Stakeholder Consultation on a Restriction for PFAS I.
refid# 0gKOyL3OnjMpbNdVQpVdb6mdm81 pages
W.
refid# qkr3jL9LwdZ352MpnVmnObqv512 pages
Open Access Article.
refid# 7Rbbvy3LZYqynZmYjO0rRak2629 pages
rECHA EUROPEAN CHEMICALS AGENCY Helsinki, 29 March 2023 BAuA Att: Ms.
refid# 9952rq336awmjjnM30Nq9zoO32 pages
Fra: Sendt: Emne: Alessia Biasioli < @eeb.org> 11. mai 202115:42 Invitation to a second series of webinars - Europe's PEAS problem: situation briefings by independent experts The European Environmental Bureau (EEB) is pleased to invite you to a second series of webinars, following the success of last year's webinars: Europe's PFAS problem: situation briefings by independent experts The new Mark Ruffalo film Dark Waters puts highly fluorinated chemicals firmly back in the public spotlight, for good reason.
refid# ymQLQjQXp5810Z4R7p88njJr41 page
Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.
refid# 0q6VyRNoJQj9zRzxBxgNd52Bn9 pages
EUROMOT Bruxelles, Belgium Socioeconomic Impact of the PFAS Restriction on EUROMOT Members Draft Socioeconomic Impact Report Client Ref.
refid# JNw2oX9ELb33ZaL5Qvoq2w2Nv26 pages
THE USE OF PFAS IN CHEMICAL PLANT EQUIPMENT AN INVENTORY STUDY Final Report September 2023 Table of Contents 0011 ExEexceuctuivtieve susmummmarayry 02 Background, scope and methodology 03 PFAS: what it is and where it is used 04 PFAS alternatives & challenges 05 PFAS management 06 PFAS ban impact 07 Appendix Executive Summary (1/4) Background and methodology In May 2023, Cefic contracted Accenture to conduct a thorough mapping of uses of PFAS in chemical industry manufacturing equipment and to investigate the use and the availability of potential alternatives, as well as waste management practices To obtain a quantitative inventory, a detailed list of equipment types used in chemicals plants was compiled.
refid# 5DXE0LevE8o9qOO3y8Q3X5MKz59 pages
Comment on Proposed Restriction of PFAS Aug 24, 2023 Japan Valve Manufactures' Association (JVMA) Japan Valve Manufacturers Association (JVMA) appreciates the opportunity to provide comments to the PFAS restriction proposal. 1.
refid# 2JN86GM7veag2Bwq6mJrgn7o611 pages
ELSEVIER Regulatory Toxicology and Pharmacology 134 (2022) 105226 Contents lists available at ScienceDirect Regulatory Toxicology and Pharmacology journal homepage: www.elsevier.com/locate/yrtph Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts J.K.
refid# pmoJEyD9dpB24Nz5wRKev6a369 pages
From: Sent: To: Cc: Subject: 27 December 2023 14:16 Enhanced Pre-application Request - EPR/BU5453IY Hi (and !)
refid# nk0N8QmyQ9eKpeZJ1YyJ18qLG2 pages